The effect of methylprednisolone on cytokine concentration and leukocyte adhesion molecule expression in an isolated cardiopulmonary bypass system

Cytokine

Volumn 22, Issue 5, 2003, Pages 149-155

  Gormley, Sheena M C ^a   Armstrong, Marilyn A ^b   McMurray, Terence J ^b   McBride, William T ^a,b  

^a ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Cardiopulmonary bypass; Cell adhesion molecules; Immune response; Interleukin 8; Methylprednisolone

Indexed keywords

CD11B ANTIGEN; CD18 ANTIGEN; CELL ADHESION MOLECULE; CYTOKINE; HEPARIN; HLA DR ANTIGEN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 8; L SELECTIN; LEUKOCYTE ADHESION MOLECULE; LEUKOCYTE ANTIGEN; METHYLPREDNISOLONE; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 2; TUMOR NECROSIS FACTOR SOLUBLE RECEPTOR 2; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; BLOOD; BLOOD ANALYSIS; BLOOD DONOR; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG EFFECT; GENETICS; GRANULOCYTE; HUMAN; IMMUNE RESPONSE; INFLAMMATION; METABOLISM; PRIORITY JOURNAL; PROTEIN DETERMINATION; STATISTICAL SIGNIFICANCE; TIME;

EID: 0038046604     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-4666(03)00135-2     Document Type: Article

References (29)

1. McBride W.T., Armstrong M.A., Crockard A.D., McMurray T.J., Rea J.M. Cytokine balance and immunosuppressive changes at cardiac surgery: contrasting response between patients and isolated CPB circuits. Br J Anaesth. 75:1995;724-733.
2. McBride W.T., Armstrong M.A., Gilliland H., McMurray T.J. The balance of pro and anti-inflammatory cytokines in plasma and bronchoalveolar lavage (BAL) at paediatric cardiac surgery. Cytokine. 8:1996;724-729.
3. Finn A., Morgan B.P., Rebuck N., Klein N., Rogers C.A., Hibbs M., et al. Effects of inhibition of complement activation using recombinant soluble complement receptor 1 on neutrophil CD11b/CD18 and L-selectin expression and release of interleukin-8 and elastase in simulated cardiopulmonary bypass. J Thorac Cardiovasc Surg. 111:1996;451-459.
4. Kirklin J.K., Westaby S., Blackstone E.H., Kirklin J.W., Chenoweth D.E., Pacifico A.D. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg. 86:1983;845-857.
5. Rinder C.S., Rinder H.M., Johnson K., Smith M., Lee D.L., Tracey J., et al. Role of C3 cleavage in monocyte activation during extracorporeal circulation. Circulation. 100:1999;553-558.
6. Rinder C.S., Rinder H.M., Smith B.R., Fitch J.C., Smith M.J., Tracey J.B., et al. Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation. J Clin Invest. 96:1995;1564-1572.
7. Finn A., Naik S., Klein N., Levinsky R.J., Strobel S., Elliott M. Interleukin-8 release and neutrophil degranulation after pediatric cardiopulmonary bypass. J Thorac Cardiovasc Surg. 105:1993;234-241.
8. Bedi A., McBride W.T., Armstrong M.A., Murray J.M., Fee J.P. Xenon has no effect on cytokine balance and adhesion molecule expression within an isolated cardiopulmonary bypass system. Br J Anaesth. 89:2002;546-550.
9. Gilliland H.E., Armstrong M.A., Upritchard S., Clarke G.F., McMurray T.J. Aprotinin inhibits leucocyte activation in an isolated cardiopulmonary bypass system. Br J Anaesth. 80:1998;551.
10. Tabardel Y., Duchateau J., Schmartz D., Marecaux G., Shahla M., Barvais L., et al. Corticosteroids increase blood interleukin-10 levels during cardiopulmonary bypass in men. Surgery. 119:1996;76-80.
11. Hill G.E., Alonso A., Thiele G.M., Robbins R.A. Glucocorticoids blunt neutrophil CD11b surface glycoprotein upregulation during cardiopulmonary bypass in humans. Anesth Analg. 79:1994;23-27.
12. Volk T., Schmutzler M., Engelhardt L., Docke W.D., Volk H.D., Konertz W., et al. Influence of aminosteroid and glucocorticoid treatment on inflammation and immune function during cardiopulmonary bypass. Crit Care Med. 29:2001;2137-2142.
13. McBride W.T., Armstrong M.A., McBride S.J. Immunomodulation: an important concept in modern anaesthesia. Anaesthesia. 51:1996;465-473.
14. Brody J.I., Pickering N.J., Fink G.B., Behr E.D. Altered lymphocyte subsets during cardiopulmonary bypass. Am J Clin Pathol. 87:1987;626-628.
15. DePalma L., Yu M., McIntosh C.L., Swain J.A., Davey R.J. Changes in lymphocyte subpopulations as a result of cardiopulmonary bypass. The effect of blood transfusion. J Thorac Cardiovasc Surg. 101:1991;240-244.
16. Ide H., Kakiuchi T., Furuta N., Matsumoto H., Sudo K., Furuse A., et al. The effect of cardiopulmonary bypass on T cells and their subpopulations. Ann Thorac Surg. 44:1987;277-282.
17. Pollock R., Ames F., Rubio P., Jones J., Reuben J., Wong W., et al. Protracted severe immune dysregulation induced by cardiopulmonary bypass: a predisposing etiologic factor in blood transfusion-related AIDS? J Clin Lab Immunol. 22:1987;1-5.
18. Rinder C.S., Mathew J.P., Rinder H.M., Tracey J.B., Davis E., Smith B.R. Lymphocyte and monocyte subset changes during cardiopulmonary bypass: effects of aging and gender. J Lab Clin Med. 129:1997;592-602.
19. Perttila J., Salo M., Pirttikangas C.O., Jalonen J., Vainio O. Effects of cardiopulmonary bypass on lymphocytes and their subset counts with or without use of autotransfusion devices. J Cardiothorac Vasc Anesth. 8:1994;532-535.
20. Gallatin W.M., Weissman I.L., Butcher E.C. A cell-surface molecule involved in organ-specific homing of lymphocytes. Nature. 304:1983;30-34.
21. Ise Y., Yamaguchi K., Sato K., Yamamura Y., Kitamura F., Tamatani T., et al. Molecular mechanisms underlying lymphocyte recirculation I. Functional, phenotypical and morphological characterization of high endothelial cells cultured in vitro . Eur J Immunol. 18:1988;1235-1244.
22. Gilliland H.E., Armstrong M.A., Uprichard S., Clarke G., McMurray T.J. The effect of aprotinin on interleukin-8 concentration and leukocyte adhesion molecule expression in an isolated cardiopulmonary bypass system. Anaesthesia. 54:1999;427-433.
23. Crockard A.D., Treacy M.T., Droogan A.G., McNeill T.A., Hawkins S.A. Transient immunomodulation by intravenous methylprednisolone treatment of multiple sclerosis. Mult Scler. 1:1995;20-24.
24. Reich K., Garbe C., Blaschke V., Maurer C., Middel P., Westphal G., et al. Response of psoriasis to interleukin-10 is associated with suppression of cutaneous type 1 inflammation, downregulation of the epidermal interleukin-8/CXCR2 pathway and normalization of keratinocyte maturation. J Invest Dermatol. 116:2001;319-329.
25. de Waal Malefyt R., Abrams J., Bennett B., Figdor C.G., de Vries J.E. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med. 174:1991;1209-1220.
26. Laichalk L.L., Danforth J.M., Standiford T.J. Interleukin-10 inhibits neutrophil phagocytic and bactericidal activity. FEMS Immunol Med Microbiol. 15:1996;181-187.
27. Vicioso M.A., Garaud J.J., Reglier-Poupet H., Lebeaut A., Gougerot-Pocidalo M.A., Chollet-Martin S. Moderate inhibitory effect of interleukin-10 on human neutrophil and monocyte chemotaxis in vitro. Eur Cytokine Netw. 9:1998;247-253.
28. Hill G.E., Alonso A., Spurzem J.R., Stammers A.H., Robbins R.A. Aprotinin and methylprednisolone equally blunt cardiopulmonary bypass-induced inflammation in humans. J Thorac Cardiovasc Surg. 110:1995;1658-1662.
29. Gormley S.M.C., McBride W.T., Armstrong M.A., Young I.S., McClean E., MacGowan S.W., et al. Plasma and urinary cytokine homeostasis and renal dysfunction during cardiac surgery. Anesthesiology. 93:2000;1210-1216.